{"name":"Cannformatics","domain":"cannformatics.com","url":"https://optimly.ai/brand/cannformatics","is_claimed":false,"categories":["ai-machine-learning","healthcare-it"],"headers":[{"header":"Overview","sections":[{"key":"short_description","label":"Tagline","shape":"text","content":"Proprietary C-Res™ biomarker technology that measures metabolic biomarkers from saliva samples to quantify individual patient responses to medical cannabis, coupled with an AI-powered bioinformatics platform to optimize products, dosage, and consumption methods for personalized treatment.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://cannformatics.com","updated_at":"2026-10-04T00:06:41.159000+00:00"},{"key":"description","label":"Description","shape":"text","content":"Cannformatics delivers predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life. The company uses proprietary Cannabis-Responsive™ (C-Res™) biomarker technology and an AI-powered cannabinoid-based pharmacometabolomics approach to personalize medical cannabis treatment, focusing initially on neurological and neuropsychiatric disorders like autism and dementia.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://cannformatics.com","updated_at":"2026-10-04T00:06:41.159000+00:00"}]},{"header":"Offerings","sections":[{"key":"core_capabilities","label":"Core capabilities","shape":"text","content":"Cannabis-Responsive™ (C-Res™) biomarker technology; AI-powered bioinformatics platform for personalized treatment guidance.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://cannformatics.com","updated_at":"2026-10-04T00:06:41.159000+00:00"},{"key":"pricing","label":"Pricing","shape":"text","content":"Not disclosed.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://cannformatics.com","updated_at":"2026-10-04T00:06:41.159000+00:00"}]},{"header":"Audience","sections":[{"key":"target_industry","label":"Target industry","shape":"text","content":"Patients with neurological and neuropsychiatric disorders (e.g., autism spectrum disorder, dementia); Healthcare Providers (HCPs) recommending medical cannabis.","source_type":"1p_website","source_label":"Brand's website","source_url":"https://cannformatics.com","updated_at":"2026-10-04T00:06:41.159000+00:00"}]}],"last_refreshed_at":"2026-10-04T00:06:41.159000+00:00","last_changed_at":"2026-10-17T23:35:07.978007+00:00","claim_url":"https://app.optimly.ai/sign-up?claim=42fa241b-45c4-4c41-8731-9a71eb71cbbe"}